North Shore Diabetes and Endocrine Associates

New Hyde Park, New York 11042

0 studies enrolling now · 15 studies all time

What they study most

Cardiovascular Disease, Coronary Heart Disease (CHD), Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2, Diabetes Type 2, Diabetes, Autoimmune, Diabetes, Type I, High Cardiovascular Risk, Obesity, Overweight, Type 1 Diabetes, Type 1 Diabetes Mellitus

Studies at this site

• Effect of Evolocumab in Patients at High Cardiovascular Risk Without Prior Myocardial Infarction or Stroke — Completed
• Mylan Insulin Aspart Study — Completed
• Efficacy and Long-Term Safety of Vildagliptin as Monotherapy in Patients With Type 2 Diabetes — Completed
• Gan & Lee Evaluation of New Biosimilar for Type 1 Lispro — Withdrawn before enrolling
• A Study to Evaluate the Effect of Long-term Treatment With BELVIQ (Lorcaserin HCl) on the Incidence of Major Adverse Cardiovascular Events and Conversion to Type 2 Diabetes Mellitus in Obese and Overweight Subjects With Cardiovascular Disease or Multiple Cardiovascular Risk Factors — Completed
• Targeting INflammation Using SALsalate in Type 2 Diabetes (TINSAL-T2D) — Completed
• Targeting Inflammation Using Salsalate for Type 2 Diabetes-Stage II — Completed
• Patient Transitioning From Exubera® Inhalation Powder to Technosphere® Insulin Inhalation Powder — NO_LONGER_AVAILABLE
• A 2-Month Safety Follow-Up Trial — Completed
• Clinical Trial Evaluating the Efficacy and Safety of Technosphere® Inhalation Insulin (TI) Inhalation Powder Using the Gen2 Inhaler — Stopped early
• Efficacy and Safety in Subjects With Type 2 Diabetes Receiving Subcutaneous Basal Insulin and Prandial Inhalation of Technosphere/Insulin Versus Subcutaneous Premixed Insulin Therapy Over a 52-Week Treatment Period and a 4-Week Follow-up — Completed
• Efficacy and Safety of Prandial Inhalation of Technosphere/Insulin in Combination With Metformin or Technosphere/Insulin Alone Versus 2 Oral Anti-Diabetic Agents in Subjects With Type 2 Diabetes — Completed
• Efficacy & Safety of Inhaled Insulin in Type 1 Diabetes — Completed
• Pulmonary Function Substudy for Subjects Enrolled in Studies MKC-TI-161, MKC-TI-162 or MKC-TI-166 — Stopped early
• Safety, Tolerability, Immunological and Clinical Efficacy of Multiple Subcutaneous Doses of DiaPep277 in Latent Autoimmune Diabetes in Adults (LADA) — Stopped early